AUL
PFE icon

AlphaGrep UK Ltd’s Pfizer PFE Stock Holding History

AlphaGrep UK Ltd’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$380K Buy
+13,541
New +$361K 0.11% 393

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

AlphaGrep UK Ltd's PFE Position: Q1 2026 in Review

AlphaGrep UK Ltd opened a new position in Pfizer (PFE) in Q1 2026: 13,541 shares worth $380K. The stake represents 0.11% of the portfolio and ranks #393 among its holdings.

2,949 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • AlphaGrep UK Ltd held 13,541 shares of Pfizer worth $380K as of Q1 2026.
  • Pfizer was a new AlphaGrep UK Ltd position in Q1 2026.
  • Pfizer made up 0.11% of AlphaGrep UK Ltd's portfolio in Q1 2026, its #393 holding.
  • 2,949 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on AlphaGrep UK Ltd's 13F filing for Q1 2026, filed 13 Aug 2026.